Considerations for universal aspirin in pre-eclampsia prevention Cost-effectiveness of supplementing current clinical practice with placental growth factor-based testsġ1. Choice of automated blood pressure monitorsĩ.1 Blood pressure devices suitable for low-resource settingsġ0. Long-term considerations associated with pre-eclampsiaĨ.2 Early and late onset of pre-eclampsiaĩ. Magnesium sulfate and other strategies for women with pre-eclampsiaĨ. ![]() Antenatal maternal and fetal surveillanceħ.5. Blood pressure, delivery, and postpartum managementħ.2. Antenatal maternal and fetal surveillanceħ. Soluble fms-like tyrosine kinase 1 to placental growth factor ratioĦ.2 Risk stratification and monitoring in asymptomatic high-risk womenĦ.2.1. Short-term prediction in women presenting with signs and symptoms of pre-eclampsiaĦ.1.2. ![]() Risk stratification of pre-eclampsia in the second and third trimesters of pregnancyĦ.1. Current method of monitoring for pre-eclampsiaĦ. Assessment of quality of evidence and grading of strength of recommendationsĥ.
0 Comments
Leave a Reply. |